Zongyang Yu

Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study

Jia‐Tao Zhang, Ye Li, Li‐Xu Yan et al. · Lung Cancer · 2019 · 51 citations · Full text

Medicine, Oncology, Chemotherapy +15

The deep learning model combining CT image and clinicopathological information for predicting ALK fusion status and response to ALK-TKI therapy in non-small cell lung cancer patients

Zhengbo Song, Tianchi Liu, Lei Shi et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 51 citations

Medicine, Oncology, Radiology +17

Hesperetin reverses P‑glycoprotein‑mediated cisplatin resistance in DDP‑resistant human lung cancer cells via modulation of the nuclear factor‑κB signaling pathway

Wencui Kong, Xiaoming Ling, Ying Chen et al. · International Journal of Molecular Medicine · 2020 · 38 citations · Full text

Medicine, Oncology, Pharmacology +15

Association Between RET Fusions and Efficacy of Pemetrexed-based Chemotherapy for Patients With Advanced NSCLC in China: A Multicenter Retrospective Study

Tianle Shen, Xingxiang Pu, Liping Wang et al. · Clinical Lung Cancer · 2020 · 35 citations

Medicine, Oncology, Pharmacotherapy +7

Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study

Wenxian Wang, Hong Wang, Pei‐Hua Lu et al. · Journal of Translational Medicine · 2019 · 34 citations · Full text

Medicine, Oncology, Pharmacology +17